Scott M. Plesha - Jul 2, 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (PTHS)

Role
CEO and President, Director
Signature
/s/ Scott M. Plesha
Stock symbol
PTHS
Transactions as of
Jul 2, 2025
Transactions value $
$0
Form type
4
Date filed
7/23/2025, 09:17 PM
Previous filing
Mar 22, 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Plesha Scott M. CEO and President, Director C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM /s/ Scott M. Plesha 2025-07-23 0001726687

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTHS Restricted Stock Units Award +83.7K 83.7K Jul 2, 2025 Common Stock 83.7K $13.50 Direct F1
transaction PTHS Stock Option Award +255K 255K Jul 2, 2025 Common Stock 255K $13.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 83,678 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.
F2 On July 2, 2025, the Reporting Person was granted stock options to purchase 255,000 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.